12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

825

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diabetes Mellitus, Type 2Hypertension
Interventions
DRUG

Placebo

Placebo matching BI 10773 low dose

DRUG

BI 10773

BI 10773 high dose once daily

DRUG

Placebo

Placebo matching BI 10773 low dose

DRUG

BI 10773

BI 10773 low dose once daily

DRUG

Placebo

Placebo matching BI 10773 high dose

DRUG

Placebo

Placebo matching BI 10773 high dose

Trial Locations (120)

Unknown

1245.48.10024 Boehringer Ingelheim Investigational Site, Huntsville

1245.48.10002 Boehringer Ingelheim Investigational Site, Phoenix

1245.48.10014 Boehringer Ingelheim Investigational Site, Lincoln

1245.48.10030 Boehringer Ingelheim Investigational Site, Long Beach

1245.48.10033 Boehringer Ingelheim Investigational Site, Long Beach

1245.48.10027 Boehringer Ingelheim Investigational Site, Los Angeles

1245.48.10041 Boehringer Ingelheim Investigational Site, Tustin

1245.48.10039 Boehringer Ingelheim Investigational Site, West Hills

1245.48.10008 Boehringer Ingelheim Investigational Site, Davie

1245.48.10025 Boehringer Ingelheim Investigational Site, Edgewater

1245.48.10001 Boehringer Ingelheim Investigational Site, Jacksonville

1245.48.10016 Boehringer Ingelheim Investigational Site, Miami

1245.48.10035 Boehringer Ingelheim Investigational Site, Palm Harbor

1245.48.10018 Boehringer Ingelheim Investigational Site, Pensacola

1245.48.10032 Boehringer Ingelheim Investigational Site, Pinellas Park

1245.48.10012 Boehringer Ingelheim Investigational Site, Marietta

1245.48.10011 Boehringer Ingelheim Investigational Site, Addison

1245.48.10019 Boehringer Ingelheim Investigational Site, Arlington Heights

1245.48.10022 Boehringer Ingelheim Investigational Site, Chicago

1245.48.10017 Boehringer Ingelheim Investigational Site, Wichita

1245.48.10010 Boehringer Ingelheim Investigational Site, Albuquerque

1245.48.10036 Boehringer Ingelheim Investigational Site, Charlotte

1245.48.10005 Boehringer Ingelheim Investigational Site, Akron

1245.48.10004 Boehringer Ingelheim Investigational Site, Kettering

1245.48.10013 Boehringer Ingelheim Investigational Site, Erie

1245.48.10020 Boehringer Ingelheim Investigational Site, Pittsburgh

1245.48.10029 Boehringer Ingelheim Investigational Site, Knoxville

1245.48.10015 Boehringer Ingelheim Investigational Site, Memphis

1245.48.10034 Boehringer Ingelheim Investigational Site, Dallas

1245.48.10007 Boehringer Ingelheim Investigational Site, Houston

1245.48.10009 Boehringer Ingelheim Investigational Site, Houston

1245.48.10042 Boehringer Ingelheim Investigational Site, Houston

1245.48.10026 Boehringer Ingelheim Investigational Site, San Antonio

1245.48.10003 Boehringer Ingelheim Investigational Site, Orem

1245.48.10023 Boehringer Ingelheim Investigational Site, Port Orchard

1245.48.20002 Boehringer Ingelheim Investigational Site, Winnipeg

1245.48.20001 Boehringer Ingelheim Investigational Site, Halifax

1245.48.20004 Boehringer Ingelheim Investigational Site, Brampton

1245.48.20006 Boehringer Ingelheim Investigational Site, Etobicoke

1245.48.20007 Boehringer Ingelheim Investigational Site, Oakville

1245.48.20005 Boehringer Ingelheim Investigational Site, Thornhill

1245.48.20003 Boehringer Ingelheim Investigational Site, Toronto

1245.48.42003 Boehringer Ingelheim Investigational Site, Benešov

1245.48.42005 Boehringer Ingelheim Investigational Site, Brno

1245.48.42002 Boehringer Ingelheim Investigational Site, Mladá Boleslav

1245.48.42006 Boehringer Ingelheim Investigational Site, Neratovice

1245.48.42008 Boehringer Ingelheim Investigational Site, Olomouc

1245.48.42004 Boehringer Ingelheim Investigational Site, Opočno

1245.48.42007 Boehringer Ingelheim Investigational Site, Příbram

1245.48.42001 Boehringer Ingelheim Investigational Site, Slaný

1245.48.45006 Boehringer Ingelheim Investigational Site, Aalborg

1245.48.45009 Boehringer Ingelheim Investigational Site, Aarhus C

1245.48.45002 Boehringer Ingelheim Investigational Site, Elsinore

1245.48.45008 Boehringer Ingelheim Investigational Site, Hellerup

1245.48.45010 Boehringer Ingelheim Investigational Site, Hillerød

1245.48.45003 Boehringer Ingelheim Investigational Site, København NV

1245.48.45001 Boehringer Ingelheim Investigational Site, Rødovre Municipality

1245.48.45004 Boehringer Ingelheim Investigational Site, Rødovre Municipality

1245.48.45005 Boehringer Ingelheim Investigational Site, Vaerløse

1245.48.45007 Boehringer Ingelheim Investigational Site, Vojens

1245.48.37203 Boehringer Ingelheim Investigational Site, Pärnu

1245.48.37201 Boehringer Ingelheim Investigational Site, Tallinn

1245.48.37202 Boehringer Ingelheim Investigational Site, Tallinn

1245.48.37204 Boehringer Ingelheim Investigational Site, Tallinn

1245.48.35802 Boehringer Ingelheim Investigational Site, Helsinki

1245.48.35805 Boehringer Ingelheim Investigational Site, Joensuu

1245.48.35806 Boehringer Ingelheim Investigational Site, Kouvola

1245.48.35803 Boehringer Ingelheim Investigational Site, Oulu

1245.48.35804 Boehringer Ingelheim Investigational Site, Pori

1245.48.35801 Boehringer Ingelheim Investigational Site, Turku

1245.48.35807 Boehringer Ingelheim Investigational Site, Turku

1245.48.33004 Boehringer Ingelheim Investigational Site, Angers

1245.48.33008 Boehringer Ingelheim Investigational Site, Bourges

1245.48.33005 Boehringer Ingelheim Investigational Site, Mont-de-Marsan

1245.48.33001 Boehringer Ingelheim Investigational Site, Nantes

1245.48.33006 Boehringer Ingelheim Investigational Site, Orthez

1245.48.33003 Boehringer Ingelheim Investigational Site, Tiercé

1245.48.33007 Boehringer Ingelheim Investigational Site, Tours

1245.48.49001 Boehringer Ingelheim Investigational Site, Berlin

1245.48.49008 Boehringer Ingelheim Investigational Site, Berlin

1245.48.49003 Boehringer Ingelheim Investigational Site, Dresden

1245.48.49004 Boehringer Ingelheim Investigational Site, Hanover

1245.48.49005 Boehringer Ingelheim Investigational Site, Lüneburg

1245.48.49002 Boehringer Ingelheim Investigational Site, Mainz

1245.48.49010 Boehringer Ingelheim Investigational Site, Nuremberg

1245.48.49009 Boehringer Ingelheim Investigational Site, Pirna

1245.48.49007 Boehringer Ingelheim Investigational Site, Schkeuditz

1245.48.49006 Boehringer Ingelheim Investigational Site, Teuchern

1245.48.96003 Boehringer Ingelheim Investigational Site, Baabda

1245.48.96001 Boehringer Ingelheim Investigational Site, Beirut

1245.48.96002 Boehringer Ingelheim Investigational Site, Lebanon

1245.48.31011 Boehringer Ingelheim Investigational Site, Breda

1245.48.31012 Boehringer Ingelheim Investigational Site, Eindhoven

1245.48.31009 Boehringer Ingelheim Investigational Site, Etten-Leur

1245.48.31014 Boehringer Ingelheim Investigational Site, Groningen

1245.48.31013 Boehringer Ingelheim Investigational Site, Leiderdorp

1245.48.31003 Boehringer Ingelheim Investigational Site, Oude Pekela

1245.48.31016 Boehringer Ingelheim Investigational Site, Rotterdam

1245.48.31006 Boehringer Ingelheim Investigational Site, Soerendonk

1245.48.31008 Boehringer Ingelheim Investigational Site, Spijkenisse

1245.48.31002 Boehringer Ingelheim Investigational Site, Swifterbant

1245.48.31015 Boehringer Ingelheim Investigational Site, Velp

1245.48.31010 Boehringer Ingelheim Investigational Site, Woerden

1245.48.31019 Boehringer Ingelheim Investigational Site, Zijndrecht

1245.48.31017 Boehringer Ingelheim Investigational Site, Zoetermeer

1245.48.47009 Boehringer Ingelheim Investigational Site, Ålesund

1245.48.47008 Boehringer Ingelheim Investigational Site, Elverum

1245.48.47007 Boehringer Ingelheim Investigational Site, Hamar

1245.48.47002 Boehringer Ingelheim Investigational Site, Kløfta

1245.48.47001 Boehringer Ingelheim Investigational Site, Oslo

1245.48.47003 Boehringer Ingelheim Investigational Site, Oslo

1245.48.47004 Boehringer Ingelheim Investigational Site, Oslo

1245.48.47005 Boehringer Ingelheim Investigational Site, Oslo

1245.48.47006 Boehringer Ingelheim Investigational Site, Sørumsand

1245.48.46002 Boehringer Ingelheim Investigational Site, Härnösand

1245.48.46004 Boehringer Ingelheim Investigational Site, Järfälla

1245.48.46003 Boehringer Ingelheim Investigational Site, Lund

1245.48.46007 Boehringer Ingelheim Investigational Site, Malmo

1245.48.46006 Boehringer Ingelheim Investigational Site, Skene

1245.48.46001 Boehringer Ingelheim Investigational Site, Stockholm

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY